Macrophages are central regulators of innate immunity, inflammation, tissue repair, and tumor progression. Among the various macrophage models available, the mouse RAW264.7 cell line remains one of the most widely used and well-characterized in vitro systems for macrophage research.
Derived from murine monocyte/macrophages transformed with Abelson murine leukemia virus (A-MuLV), RAW264.7 cells exhibit stable growth, unlimited passaging capability, and robust responsiveness to inflammatory stimuli. Unlike primary macrophage models, RAW264.7 cells do not require animal sacrifice or lengthy differentiation procedures, making them an ideal platform for macrophage polarization studies.
![Figure 1. Differences between M1 and M2 macrophages[1]](https://cdn.shopify.com/s/files/1/0803/9419/1166/files/1_cb551904-7c77-4f4b-b301-2223d3887bcd_1024x1024.png?v=1782695350)
Figure 1. Differences between M1 and M2 macrophages[1]
Why Choose RAW264.7 Cells for Macrophage Polarization?
Compared with primary bone marrow-derived macrophages (BMDMs), alveolar macrophages, or peritoneal macrophages, RAW264.7 cells offer several advantages:
|
Advantage |
Description |
|
No animal isolation required |
No mouse sacrifice or primary cell isolation is needed. Cells can be cultured immediately after thawing. |
|
No differentiation step |
Unlike BMDMs, RAW264.7 cells do not require a 7-day differentiation process. |
|
Strong polarization response |
Highly responsive to LPS and cytokine stimulation, producing clear M1/M2 phenotypes. |
|
Well-established model |
One of the most cited macrophage models in immunology and inflammation research. |
|
Cost-effective |
Stable growth and easy maintenance make it suitable for long-term studies and large-scale screening. |
Common Applications of RAW264.7 Polarization Models
|
Research Area |
Applications |
|
Macrophage Biology |
M1/M2 polarization studies and mechanism research |
|
Innate Immunity |
NF-κB, TLR, and NLRP3 inflammasome signaling pathways |
|
Inflammatory Diseases |
Sepsis, metabolic inflammation, and acute organ injury models |
|
Tumor Immunology |
Tumor-associated macrophage (TAM) models and immunotherapy evaluation |
|
Drug Discovery |
Small molecule, cytokine, and natural product screening |
|
Cell Function Studies |
Phagocytosis assays, nanomaterial safety evaluation, and infection research |
Mouse RAW264.7 Cell Polarization Induction Set
To simplify macrophage polarization workflows, Yeasen developed the Mouse RAW264.7 Cell Polarization Induction Set (Cat# 92648ES), a ready-to-use cytokine combination optimized according to widely accepted literature protocols.
|
Cat.NO. |
Name |
92648ES08 |
92648ES50 |
Recommended Working Concentration |
Appearance |
|
92648ES-A |
Mouse IL-4 Protein |
5 μg |
50 μg |
20 ng/mL |
Freeze-dried powder |
|
92648ES-B |
Mouse IFN-γ Protein |
5 μg |
50 μg |
25 ng/mL |
Freeze-dried powder |
|
92648ES-C |
Lipopolysaccharide (LPS) |
5 mg |
5 mg |
100 ng/mL |
Freeze-dried powder |
M1 vs M2 Polarization Conditions
Classical M1 macrophage polarization is induced using IFN-γ (25 ng/mL) and LPS (100 ng/mL). Alternatively, M2 polarization is driven by IL-4 (20 ng/mL), with optional supplementation of IL-13 or IL-10 to further enhance the M2 phenotype.
|
Polarization Type |
Cytokines |
Incubation |
Representative Markers |
Typical Applications |
|
M1 (Classical Activation) |
IFN-γ(25 ng/mL) + LPS(100 ng/mL) |
24 h |
iNOS, TNF-α, CD86 |
Inflammation, infection, anti-tumor immunity |
|
M2 (Alternative Activation) |
IL-4 (optional IL-13 or IL-10) |
24 h |
Arg1, CD206, Ym1 |
Tissue repair, fibrosis, tumor microenvironment |
Key Advantages of the Polarization Kit
|
Feature |
Benefit |
|
Literature-validated formulation |
Eliminates trial-and-error optimization |
|
High-activity recombinant cytokines |
Consistent M1/M2 induction performance |
|
Low endotoxin (<0.1 EU/μg) |
Reduces non-specific inflammatory responses |
|
Lyophilized format |
Minimizes activity loss during storage |
|
Complete protocol support |
Includes polarization workflow and marker recommendations |
Experimental Protocol
M1 Polarization
- Seed RAW264.7 cells and culture for 24 hours.
- Replace medium with DMEM containing 2% FBS.
- Add IFN-γ (25 ng/mL) and LPS (100 ng/mL).
- Incubate for 24 hours.
- Analyze CD86 expression by flow cytometry or assess inflammatory markers by qPCR.
M2 Polarization
- Seed RAW264.7 cells and culture for 24 hours.
- Replace medium with DMEM containing 2% FBS.
- Add IL-4 (20 ng/mL).
- Incubate for 24 hours.
- Analyze CD206 expression by flow cytometry or evaluate M2 markers by qPCR.
Experimental Case Data

Figure 2. Flow cytometry scatter plots of M1/M2 polarization.
I. M1 Macrophage Polarization
1. Cell Seeding: Seed 2 × 10^5 cells per well into a 6-well cell culture plate (Cat#84011ES). (Note: Avoid seeding too many cells, as this may compromise polarization efficiency.) Incubate at 37°C with 5% CO₂ for 24 hours to allow cells to adhere fully.
2. M1 Induction: Replace the culture medium with DMEM (Cat#41401ES) supplemented with 2% FBS (Cat#40132ES) to minimize the influence of cytokines present in serum. Add recombinant mouse IFN-γ (25 ng/mL) and LPS (100 ng/mL). Set up a control group (cells only, without induction agents). Incubate at 37°C with 5% CO₂ for 24 hours.
3. Flow Cytometry Protocol:
3.1. Cell Harvesting: After 24 hours of cytokine treatment, discard the culture supernatant and wash the cells once with PBS. Discard the supernatant, then gently pipette the adherent cells with PBS to resuspend them. Centrifuge to collect the cells.
3.2. Cell Counting: Resuspend the cells in 0.5 mL of 1% BSA. Calculate the total cell count and assess cell viability, which must be greater than 95%.
3.3. Antibody Incubation: Add PE Rat anti-Mouse CD86 mAb (refer to the datasheet for the recommended antibody amount) or the corresponding isotype control. Incubate at room temperature for 30 minutes.
3.4. Cell Washing: Wash the cells with PBS to remove unbound antibodies, and resuspend them again in PBS.
3.5. Viability Staining: Add Fixable Viability Kit to each well (refer to the datasheet for the recommended amount). Incubate at room temperature in the dark for 15 minutes.
3.6. Cell Washing: Wash the cells with 1% BSA to remove residual antibodies, and resuspend the cells in 1% BSA.
3.7. Flow Cytometry Analysis: Proceed to acquire data on the flow cytometer.
II. M2 Macrophage Polarization
1. Cell Seeding: Seed 2 × 10^5 cells per well into a 6-well cell culture plate. (Note: Avoid seeding too many cells, as this may compromise polarization efficiency.) Incubate at 37°C with 5% CO₂ for 24 hours to allow cells to adhere fully.
2. M2 Induction: Replace the culture medium with DMEM supplemented with 2% FBS to minimize the influence of cytokines present in serum. Add recombinant mouse IL-4 (20 ng/mL). Set up a control group (cells only, without induction agents). Incubate at 37°C with 5% CO₂ for 24 hours.
3. Flow Cytometry Protocol:
3.1. Cell Harvesting: After 24 hours of cytokine treatment, discard the culture supernatant and wash the cells once with PBS. Discard the supernatant, then gently pipette the adherent cells with PBS to resuspend them. Centrifuge to collect the cells.
3.2. Cell Counting: Resuspend the cells in 0.5 mL of 1% BSA. Calculate the total cell count and assess cell viability, which must be greater than 95%.
3.3. Viability Staining: After centrifugation, resuspend the cells in PBS to a density of 1 × 10^7 cells/mL. Aliquot 100 μL per well into a 96-well plate or flow cytometry tubes. Add the Fixable Viability Kit (refer to the datasheet for the recommended amount) and incubate at room temperature in the dark for 15 minutes. Centrifuge at 300 × g for 5 minutes and discard the supernatant.
3.4. Fixation: Resuspend and fix the cells in 0.2 mL of 4% paraformaldehyde (PFA). Incubate at room temperature in the dark for 15 minutes. Centrifuge at 300 × g for 5 minutes and discard the supernatant (to remove residual fixative).
3.5. Permeabilization: Resuspend and permeabilize the cells in 0.2 mL of 1X Permeabilization Buffer. Incubate at room temperature in the dark for 30 minutes. Centrifuge at 400 × g for 5 minutes and discard the supernatant.
3.6. Cell Washing: Resuspend the cells in 0.2 mL of 1X Permeabilization Buffer per well. Centrifuge at 400 × g for 5 minutes and discard the supernatant.
3.7. Fc Blocking: Add 0.1 mL of 1X Permeabilization Buffer and 2 μg of CD16/CD32 (Cat#771585ES60) antibody to each well for Fc blocking. Incubate on ice for 30 minutes. Centrifuge at 400 × g for 5 minutes and discard the supernatant.
3.8. Antibody Incubation: Add 0.1 mL of 1X Permeabilization Buffer and APC anti-Mouse CD206 mAb (refer to the datasheet for the recommended antibody amount) or APC Rat IgG Isotype Control Antibody to each well. Incubate at room temperature for 30 minutes. Centrifuge at 400 × g for 5 minutes and discard the supernatant (to remove unbound antibodies).
3.9. Cell Washing: Wash the cells by adding 0.2 mL of 1% BSA per well. Centrifuge at 400 × g for 5 minutes and discard the supernatant. Repeat this washing step twice. Finally, resuspend the cells in 200 μL of 1% BSA.
3.10. Flow Cytometry Analysis: Proceed to acquire data on the flow cytometer.
Related Products
|
Product Category |
Catalog Number |
Product Name |
|
Cytokines |
Mouse RAW264.7 Cell Polarization Induction Set |
|
|
Cell Culture |
41401ES |
DMEM High Glucose Medium (with L-glutamine, sodium pyruvate 110 mg/L; without HEPES and antibiotics) |
|
Cell Culture |
41403ES |
1× PBS, Cell Culture Grade |
|
Cell Culture |
Penicillin-Streptomycin (100×), Suitable for Cell Culture |
References
Ernestina A, Marcarious M T, Rui Z, et al. Exploring the polarization of M1 and M2 macrophages in the context of skin diseases. Mol Biol Rep. 2024 Feb 1;51(1):269.
